Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Interest Expense : E£-222 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's interest expense for the three months ended in Mar. 2024 was E£ -61 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was E£-222 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Operating Income for the three months ended in Mar. 2024 was E£ 80 Mil. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Interest Expense for the three months ended in Mar. 2024 was E£ -61 Mil. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Interest Coverage for the quarter that ended in Mar. 2024 was 1.31. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Interest Expense Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Interest Expense Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-105.80

-96.65

-91.03

-89.07

-191.20

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-30.56	-44.39	-57.65	-58.60	-61.02

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£-222 Mil.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Interest Expense for the three months ended in Mar. 2024 was E£-61 Mil. Its Operating Income for the three months ended in Mar. 2024 was E£80 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was E£9 Mil.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	80.003	/	-61.024
	=	1.31

The higher the ratio, the stronger the company's financial strength is.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY

Website

https://www.ramedapharma.com

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. It is engaged in the manufacture and sale of branded generic pharmaceutical products nutraceuticals, cosmeceuticals, food supplements, medical devices, and veterinary products. The firm is engaged in therapeutic areas namely systemic anti-infectives, alimentary tract and metabolism, genitourinary system and sex hormones, cardiovascular system, nervous system, and blood and blood-forming organs.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Headlines

No Headlines